0000950133-01-502610 Sample Contracts

SEPTEMBER 2001 NOTE PURCHASE AGREEMENT by and between NOVAVAX, INC. and KING PHARMACEUTICALS, INC. Dated as of September 7, 2001

Note Purchase Agreement • September 14th, 2001 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Note Purchase Agreement
• Filed
  September 14th, 2001
• Company
  Novavax Inc
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

ALLONGE TO 4% CONVERTIBLE SENIOR NOTE

4% Convertible Senior Note • September 14th, 2001 • Novavax Inc • Biological products, (no disgnostic substances)

• Contract Type
  4% Convertible Senior Note
• Filed
  September 14th, 2001
• Company
  Novavax Inc
• Industry
  Biological products, (no disgnostic substances)

THIS ALLONGE TO 4% CONVERTIBLE SENIOR NOTE (the “Allonge”), is made September 7, 2001, between King Pharmaceuticals, Inc. (“Payee”) and Novavax, Inc. (“Company”).

FIRST AMENDMENT TO INVESTOR RIGHTS AGREEMENT

Investor Rights Agreement • September 14th, 2001 • Novavax Inc • Biological products, (no disgnostic substances)

• Contract Type
  Investor Rights Agreement
• Filed
  September 14th, 2001
• Company
  Novavax Inc
• Industry
  Biological products, (no disgnostic substances)

THIS FIRST AMENDMENT TO INVESTOR RIGHTS AGREEMENT (this “Amendment”) is entered into as of September 7, 2001, by and between KING PHARMACEUTICALS, INC., a Tennessee corporation (“King”), and NOVAVAX, INC., a Delaware corporation (the “Company”).